IL10 and breast carcinoma: Although traditionally associated with highly proliferative characteristics through the secretion of IL-4, IL-6, and IL-10, which activate M2 macrophages [107,108], a recent study suggests that Th2 cells can directly block mammary carcinogenesis by inducing a terminal differentiation of breast cancer cells [109].